HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johannes Rehm Selected Research

Islet Cell Adenoma (Islet Cell Tumors)

3/2012Epithelial-mesenchymal transition is a critical step in tumorgenesis of pancreatic neuroendocrine tumors.
1/2012Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumors.
11/2011Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms.
3/2011Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johannes Rehm Research Topics

Disease

4Islet Cell Adenoma (Islet Cell Tumors)
03/2012 - 03/2011
4Neoplasms (Cancer)
03/2012 - 03/2011
1Necrosis
05/2016
1Mediastinitis
05/2016
1Primitive Neuroectodermal Tumors (PNET)
03/2012

Drug/Important Bio-Agent (IBA)

1Pharmaceutical PreparationsIBA
03/2012
1Snail Family Transcription FactorsIBA
03/2012
1Cadherins (E-Cadherin)IBA
03/2012
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2012
1Sorafenib (BAY 43-9006)FDA Link
01/2012
1sonidegibIBA
11/2011
1AntimetabolitesIBA
03/2011
1cyclopamineIBA
03/2011

Therapy/Procedure

4Therapeutics
05/2016 - 03/2011